PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
AP2M1 7 Target Disease Infection 766,637 1 0.00 -0.93 0.14 0.55
CD62L/L-Selectin 8 Target Disease Infection 766,637 1 0.00 -0.94 0.12 0.55
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
Anakinra (Kineret)- FDA 10 Drug Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
Alpha (Prolastin)- FDA 13 Drug Disease Infection 766,637 1 0.00 -0.96 0.08 0.54
Arava (Leflunomide)- FDA 14 Drug Disease Infection 766,637 1 0.00 -0.96 0.07 0.54
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
Anesthesia Local 18 Disease Disease Infection 766,637 1 0.00 -0.97 0.06 0.53
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
Aralen (Chloroquine)- FDA 19 Drug Disease Infection 766,637 2 0.00 -0.95 0.11 0.55
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
Adefovir Dipivoxil (Hepsera)- FDA 22 Drug Disease Infection 766,637 6 0.00 -0.85 0.27 0.57
Arthralgia Syndrome 23 Disease Disease Infection 766,637 3 0.00 -0.93 0.13 0.55
Carcinoma Bladder 25 Disease Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
Epigen 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
DAPK2 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
Sodium Channel Nav1.8 31 Target Disease Infection 766,637 1 0.00 -0.98 0.03 0.53
BD3 32 Target Disease Infection 766,637 4 0.00 -0.94 0.12 0.55
D4-GDI 35 Target Disease Infection 766,637 3 0.00 -0.96 0.09 0.54
Atridox (Doxycycline Hyclate)- FDA 38 Drug Disease Infection 766,637 5 0.00 -0.93 0.13 0.55
Abacavir Sulfate 41 Drug Disease Infection 766,637 7 0.00 -0.91 0.17 0.56
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
CAMK2A 42 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
Amoxil (Amoxicillin)- FDA 44 Drug Disease Infection 766,637 9 0.00 -0.89 0.20 0.56
BAFFR 44 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
DNAJB1 44 Target Disease Infection 766,637 1 0.00 -0.99 0.02 0.52
Dopamine Receptor D3 45 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
High Affinity Nerve Growth Factor Receptor 47 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Carcinoma Squamous Cell 47 Disease Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Phosphodiesterase 4b 54 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
A1M 59 Target Disease Infection 766,637 3 0.00 -0.97 0.05 0.54
Glutathione S-Transferase Theta-1 70 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
BD2 76 Target Disease Infection 766,637 4 0.00 -0.97 0.05 0.54
CXCL7 76 Target Disease Infection 766,637 9 0.00 -0.94 0.12 0.55
Extrapyramidal Disorder 81 Disease Disease Infection 766,637 2 0.00 -0.99 0.02 0.52
Chorismate Synthase 85 Target Disease Infection 766,637 2 0.00 -0.99 0.02 0.52
ENO2 87 Target Disease Infection 766,637 3 0.00 -0.98 0.03 0.53
B-R1 90 Target Disease Infection 766,637 1 0.00 -0.99 0.01 0.51
Post Nasal Drip 100 Disease Disease Infection 766,637 15 0.00 -0.92 0.15 0.56
ACRP30 102 Target Disease Infection 766,637 1 0.00 -1.00 0.01 0.50
Crohns Disease 107 Disease Disease Infection 766,637 8 0.00 -0.96 0.07 0.55
APOH 110 Target Disease Infection 766,637 4 0.00 -0.98 0.04 0.53
Leukemia T Cell 113 Disease Disease Infection 766,637 6 0.00 -0.97 0.05 0.54
Parkinsons Disease 124 Disease Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
FABP3 134 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52
Diaper Rash 155 Disease Disease Infection 766,637 15 0.00 -0.95 0.10 0.55
AMBP 160 Target Disease Infection 766,637 5 0.00 -0.98 0.03 0.53
CCNB1 160 Target Disease Infection 766,637 3 0.00 -0.99 0.02 0.52